Induction Therapy: Clinical Trials

1 trial for Induction Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Induction Therapy: new trials by email Literature Review of Induction Therapy trials Research Report on Induction Therapy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Thymoglobulin [Anti-thymocyte Globulin (rabbit)], Simulect (basliximab) - Cadaveric Donor Renal Transplantation, Acute Renal Allograft Rejection
Phase 2CompletedGenzyme, a Sanofi Company2402000-05-012015-03-18

Interventions

Antilymphocyte Serum (1)  ·  Basiliximab (1)  ·  thymoglobulin (1)

Sponsors

Genzyme, a Sanofi Company (1)

Countries

France (1)  ·  Germany (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 17093248, PMID 26285695